SPY304.71+0.39 0.13%
DIA254.71+0.42 0.17%
IXIC9,520.22+30.35 0.32%

Bellicum Pharmaceuticals Q1 EPS $1.090 May Not Compare To $(0.550) YoY

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly earnings of $1.090 per share. This is a 298.18 percent increase over losses of $(0.550) per share from the same period last year.

Benzinga · 05/07/2020 20:45

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly earnings of $1.090 per share. This is a 298.18 percent increase over losses of $(0.550) per share from the same period last year.